NovoNutrients, a biotech innovator specializing in converting CO₂ emissions into high-quality protein, announced a successful first closing of its Series A financing. The funding round totals $18 million, comprising $10.3 million in new capital and $8 million from converted SAFEs. Woodside Energy, a prominent global energy firm, led the round with co-leadership from CM Venture […]
Aptamer Group plc (AIM: APTA), an innovator in the life sciences sector, has announced new agreements worth up to £275,000 for the development of its proprietary Optimer binders. These agreements involve three of the top ten global pharmaceutical companies and underline the expanding commercial interest in Aptamer’s technology. The deals also include potential for additional […]
ANGLE plc, a leading innovator in liquid biopsy and circulating tumour cell (CTC) solutions, has announced a significant supplier agreement with global biopharmaceutical leader AstraZeneca PLC. The collaboration focuses on developing a novel methodology for the detection of micronuclei in CTCs, utilizing ANGLE’s DNA damage response (DDR) assay, a key marker in cancer diagnostics and […]
In a significant move, NanoString Technologies, Inc. (OTC: NSTGQ), a pioneer in life science tools for discovery and translational research, has announced an agreement with Patient Square Capital, a leading healthcare investment firm. This arrangement places Patient Square Capital as the “stalking horse” bidder in a court-supervised sales process, aiming to acquire substantially all assets […]